Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma.

Source:http://linkedlifedata.com/resource/pubmed/id/11775393

Download in:

View as

General Info

PMID
11775393